New pill targets hard-to-treat obesity after brain injury
Disease control
Completed
This study tested an experimental daily pill, LB54640, in 28 people aged 12 and older with hypothalamic obesity—a condition where brain injury causes rapid, severe weight gain. For the first 14 weeks, some received the drug and some a placebo to see if it safely reduces weight an…
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC